Type | Description | Contributor | Date |
---|---|---|---|
Post created | Pocketful Team | Oct-10-25 |
Read Next
- Best Dividend Tracker Apps in India
- Best Plastic Stocks in India
- JioHotstar Company Case Study: Merger, Business Model & SWOT Analysis
- Best ESG Stocks in India
- Tax on Gold Investment in India: Physical, Digital & SGB Explained
- Best Stock Alert Apps in India
- Best Aquaculture Stocks in India 2025
- List of Quick Commerce Company Stocks
- How to Set Financial Goals for Your Future
- Digital Gold vs Gold ETF: Which is Better?
- Best Cloud Computing Stocks in India 2025
- Government Penny Stocks in India 2025
- Best Safe Investments with High Returns in India
- Best Diamond Stocks in India
- Margin of Safety: Definition and Examples
- Free Apps for Stock Investments in India
- Best Waste Management Stocks in India 2025
- Top Hospital Stocks to Buy in India 2025
- Best Stock Market News Apps in India 2025
- What is Dividend ETF?
- Blog
- top biotech stocks in india
Top Biotech Companies Stocks in India

Biotechnology is now one of India’s most innovative and emerging industries. This sector offers an opportunity for creating wealth over time because there is a rising need for affordable medicines, vaccines, and innovative therapies.
In today’s blog post, we will give you an overview of the top biotech companies in India, along with the future of this sector.
What are Biotech Companies’ Stocks?
Biotech companies’ stocks are the shares of those companies which are primarily engaged in medicines, vaccines, etc. related to the healthcare sector. Through innovative technologies,they develop advanced medicines which are used to treat various diseases related to cancer, etc.
Top Biotech Stocks to Buy in India
- Biocon Limited
- Anthem Biosciences Limited
- Onesource Speciality Pharma Limited
- Sai Lifesciences Limited
- Acutaas Chemicals Limited
- Glaxosmithkline Pharma Limited
- Syngene International Limited
- Indegene Limited
- Windlas Biotech Limited
- Vivo Biotech Limited
Company | Current Market Price (INR) | Market Capitalisation (in INR crore) | 52-Week High | 52-Week Low |
---|---|---|---|---|
Biocon Limited | 341 | 45590 | 406 | 291 |
Anthem Biosciences Limited | 763 | 42871 | 874 | 702 |
Onesource Speciality Pharma Limited | 1840 | 21077 | 2250 | 1163 |
Sai Lifesciences Limited | 861 | 18010 | 943 | 635 |
Acutaas Chemicals Limited | 1318 | 10789 | 1530 | 727 |
Glaxosmithkline Pharma Limited | 2660 | 45117 | 3516 | 1921 |
Syngene International Limited | 623 | 25097 | 961 | 599 |
Indegene Limited | 561 | 13472 | 737 | 485 |
Windlas Biotech Limited | 906 | 1909 | 1198 | 665 |
Vivo Biotech Limited | 37.2 | 74.4 | 56.9 | 31.2 |
Read Also: List Of Best Pharma Stocks in India
Overview of Top Biotech Stocks to Buy in India
The overview of top biotech stocks to buy in India is as follows:
1. Biocon Limited
Kiran Mazumdar Shaw started Biocon Limited in 1978. It is now one of India’s top biopharmaceutical companies. The company started as a manufacturer of industrial enzymes and later transformed into a major player in the biopharmaceutical industry, focusing on new and affordable medicines. It has a strong presence across more than 120 countries. The company’s headquarters is situated in Bengaluru.
2. Anthem Biosciences Limited
The company was founded in 2006 by Ajay Bhardwaj, Ganesh Sambasivam, and K. Ravindra Chandrappa. The company started operations in 2007 with its Unit I facility at Bommasandra. It started with a 6 KL custom synthesis plant and later added a small fermentation capacity for discovery biology. Anthem Biosciences Limited is a well-known Indian Contract Research, Development, and Manufacturing Organisation (CRDMO). It has its headquarters in Bengaluru.
3. OneSource Speciality Pharma Limited
OneSource Speciality Pharma Limited is a biopharmaceutical CDMO (Contract Development & Manufacturing Organisation) with headquarters in Bengaluru, which offers comprehensive services for specialty pharmaceuticals and biologics. In June 2007, it was incorporated as Inbiopro Solutions Private Limited. In 2014, it changed its name to Stelis Biopharma Private Limited; in 2021, it went public; and in February 2024, it finally changed its name to Onesource Speciality Pharma Limited.
4. Sai Lifesciences Limited Company
The company was incorporated in 1999 and initially was named Sai Dru Syn Laboratories Limited. Later in 2012, the company finally changed its name to Sai Life Sciences Limited. The company merged with Prasad Drugs in 2004 and acquired Merrifield Pharma in 2006. It also has various R&D facilities in the USA and UK. Currently serves more than 250 global innovator pharma and biotech clients. The company’s headquarters is situated in Hyderabad.
5. Acutaas Chemicals Limited
The company was founded in 2004. Initially, it was a partnership firm, and later in 2007, it converted into a private limited company. Finally, in 2018, it became a publicly limited company. Recently, in 2025, the company changed its name to Acutaas Chemicals Limited. Acutaas has become increasingly significant in new fields, such as battery chemicals and semiconductor materials. This indicates that the company is dedicated to innovation. The company’s headquarters is situated in Gujarat.
6. Glaxosmithkline Pharma Limited
Glaxosmithkline Pharma Limited is generally known as GSK India. The company was incorporated in 1924, and initially it was named HJ Foster and Company Limited. In 1950, it changed its name to Glaxo Laboratories India Limited. Currently, it is one of the largest research-based pharma and healthcare companies. The vaccines offered by this company for immunisation like hepatitis A and B, influenza, chickenpox, etc. The company’s headquarters is situated in Mumbai.
7. Syngene International Limited
Syngene International Limited company was founded in 1993 and is promoted by Biocon and Kiran Mazumdar-Shaw. It became a subsidiary company of Biocon in 2002. Initially from CRDMO, it has started providing services in development, biologics, and clinical supplies etc. The company got itself listed in 2015. Its headquarters are situated in Bengaluru.
8. Indegene Limited
Indegene Limited company was founded in 1998 by entrepreneurs. The company commercialisation company that helps emerging biotech and biopharma companies and provides them with clinical products, marketing, technology, and its activation. They got major funding in 2021 from the private equity firm Carlyle Group and Brighton Park Capital. The company launched its IPO in 2024 and became a publicly listed company. Its headquarters are situated in Bengaluru.
9. Windlas Biotech Limited
Windlas Biotech Limited company was incorporated in 2001 by Ashok Kumar Windlass and started its first production plant in Dehradun. Later, it established various plants across the country, manufacturing tablets, capsules, etc. Along with the domestic clients, they also serve international clients. The company launched its IPO in 2021. The company’s headquarters is situated in Dehradun.
10. Vivo Biotech Limited
Vivo Biotech Limited was incorporated in 1987, and initially, it was named Sunshine Factors and Exports Limited. Later in 2002, the finally changed its name to Vivo Bio Tech Limited. Initially, the company focused on animal breeding and lab services. In 2010, the organisation achieved AAALAC International Accreditation. The company’s headquarters is situated in Hyderabad.
Read Also: List Of Best Healthcare Stocks in India
Key Performance Indicators (KPIs)
The key performance metrics of top biotech stocks are as follows:
Company | Debt to Equity | ROE (%) | ROCE (%) | Operating Profit Margin (%) | Net Profit Margin (%) |
---|---|---|---|---|---|
Biocon Limited | 0.85 | 4.76 | 6.25 | 20.70 | 9.12 |
Anthem Biosciences Limited | 0.05 | 20.80 | 28.50 | 36.40 | 24.46 |
Onesource Speciality Pharma Limited | 0.13 | 3.34 | 5.52 | 33.10 | 7.26 |
Sai Lifesciences Limited | 0.17 | 11.00 | 14.00 | 26.20 | 10.10 |
Acutaas Chemicals Limited | 0 | 16.00 | 19.90 | 24.40 | 15.90 |
Glaxosmithkline Pharma Limited | 0 | 46.90 | 63.20 | 32.00 | 23.30 |
Syngene International Limited | 0.12 | 10.49 | 13.5 | 28.90 | 13.00 |
Indegene Limited | 0.04 | 20.60 | 24.80 | 19.20 | 14.70 |
Windlas Biotech Limited | 0.05 | 12.81 | 17.00 | 12.60 | 7.98 |
Vivo Biotech Limited | 0.69 | 5.68 | 9.04 | 44.1 | 8.06 |
Benefits of Investing in Biotech Stocks
The key benefits of investing in Biotech Stocks are as follows:
- Innovative Industry: The biotech industry is based on constant new ideas in fields like genetics, cell therapy, biologics, and vaccines. This keeps the industry evolving while making it attractive for long-term investors.
- Defensive Sector: The biotech and healthcare industries are considered defensive in nature, as medicines and healthcare services are essential even during economic downturns.
- Government Support: Many governments provide incentives, subsidies, and favourable regulations to support biotech R&D, which increases growth prospects.
Factors to Consider Before Investing in Biotech Stocks
There are various factors which one should consider before investing in Biotech Stocks, a few of which are as follows:
- Financial Performance: Before investing in Biotech stocks, one is required to consider the financial performance of the company and must invest in companies having higher profit margins.
- Regulatory Approvals: Approval from regulatory bodies, including the US FDA, EMA, or CDSCO in India, is crucial for biotech companies. Any rejection from these regulatory bodies can significantly impact stock prices.
- Management: The performance of biotech companies depends on the expertise of leadership. Hence, one should invest in companies with stable and experienced management.
Read Also: Best Pharma Penny Stocks
Future of Biotech Stocks
The future looks promising for biotech stocks, thanks to rapid progress in genetics, biotechnology, and personalized healthcare. With rising global demand for better medical services, aging populations, and an increasing number of chronic illnesses, biotech companies are expected to play a key role in creating breakthrough therapies, vaccines, and diagnostics.
The industry in India is already valued at around ₹1,150 crore and is projected to grow nearly four times to about ₹4,000 crore by 2030. For investors, this growth story highlights biotech as one of the most exciting sectors to watch in the coming years.
Conclusion
On a concluding note, India’s biotechnology industry is shaping up as a hub of innovation, driven by strong R&D, growing healthcare needs, and supportive government policies. Leading biotech firms are not only creating new medicines and vaccines but also helping India emerge as a global center for affordable and advanced treatments.
That said, investing in biotech stocks isn’t without risks—clinical trials can fail, and regulatory approvals often take time. If you’re considering investing in this sector, it’s best to weigh the opportunities against the risks and consult a financial advisor before making a decision.
Frequently Asked Questions (FAQs)
Name some top biotech stocks to invest in India?
The top biotech stocks to invest in India are Biocon Limited, Anthem Biosciences Limited, OneSource Speciality Pharma Limited, Sai Lifesciences Limited Company, Acutaas Chemicals Limited, etc.
Is it safe to invest in biotech companies?
Yes, it is safe to invest in biotech companies, as this industry is considered defensive in nature, as the demand for healthcare-related products remains stable even during the economic downturn.
Is there any risk related to investing in biotech companies?
Yes, there are certain risks related to investing in biotech companies, such as regulatory approval by the authorities, trials by the companies, and technologies used by them.
Are biotech companies export-oriented?
Yes, most of the Indian biotech companies export the APIs (Active Pharmaceutical Ingredients) to various international companies.
Do the biotech companies declare dividends?
Yes, most of the biotech companies declare regular dividends; however, various companies reinvest the profit into their business research department. Therefore, before investing with an objective to get passive income from dividends from biotech companies, one should check the dividend yield of such companies.
Disclaimer
The securities, funds, and strategies discussed in this blog are provided for informational purposes only. They do not represent endorsements or recommendations. Investors should conduct their own research and seek professional advice before making any investment decisions.
Article History
Table of Contents
Toggle